{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:22:56Z","timestamp":1785680576616,"version":"3.56.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>Primary tumor site determination for gastrointestinal (GI) tract and pancreaticobiliary (PB) tree carcinomas that present as metastasis of unknown primary can be problematic. Annexin A10 (ANXA10), claudin 18 (CLDN18), and trefoil factor 1 (TFF1) have been identified through expression profiling as markers of gastric lineage commitment; sex-determining region Y (SRY)-box transcription factor 2 (SOX2) expression has been reported in several tumor types, including gastric adenocarcinomas. We evaluated the diagnostic utility of immunohistochemistry for ANXA10, CLDN18, SOX2, and TFF1 for determining the site of origin for GI\/PB adenocarcinomas. Immunohistochemistry for all 4 markers was performed on tissue microarrays including 559 GI\/PB tumors and 421 other tumors. H-scores were calculated as the product of the intensity (0 to 3) and extent (percentage, 0% to 100%) of staining. Positive staining was defined as &gt;5% staining. ANXA10 expression was most frequent in pancreatic adenocarcinomas when compared with all other GI\/PB tumors (96.4% vs. 43.5%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Strong staining for ANXA10 (H-score \u2265200) distinguished pancreatic ductal adenocarcinoma from intrahepatic cholangiocarcinoma and adenocarcinomas of the gallbladder and colorectum (69.6% vs. 0%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Triple positivity for ANXA10, CLDN18, and SOX2 was more frequent in esophagogastric tumors than in other GI\/PB tumors (22.6% vs. 4.1%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). TFF1 expression was observed in nearly all tumor types. Staining for ANXA10, CLDN18, and SOX2 as part of a panel may aid in distinguishing esophagogastric adenocarcinomas from lower GI\/PB tumors. ANXA10 staining may be particularly useful in distinguishing pancreatic adenocarcinomas from intrahepatic cholangiocarcinoma and adenocarcinomas of the gallbladder and colorectum.<\/jats:p>","DOI":"10.1097\/pas.0000000000001994","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T22:09:10Z","timestamp":1675375750000},"page":"440-452","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary"],"prefix":"10.1097","volume":"47","author":[{"given":"Raymond A.","family":"Isidro","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abukhiran","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Dunseth","sequence":"additional","affiliation":[{"name":"Citizens Memorial Healthcare, Bolivar, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Gosse","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Carver College of Medicine, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Humble","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Carver College of Medicine, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Pelletier","sequence":"additional","affiliation":[{"name":"Winfield Pathology Consultants, Oak Brook, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Varshney","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Mississippi University Hospital, Jackson, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Bellizzi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Carver College of Medicine, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.1988.00380090101024","article-title":"Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients","volume":"148","author":"Le Chevalier","year":"1988","journal-title":"Arch Intern Med"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.ejca.2007.06.023","article-title":"Switching benchmarks in cancer of unknown primary: from autopsy to microarray","volume":"43","author":"Pentheroudakis","year":"2007","journal-title":"Eur J Cancer"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2021.05.057","article-title":"Hybrid stomach-intestinal chromatin states underlie human Barrett\u2019s metaplasia","volume":"161","author":"Singh","year":"2021","journal-title":"Gastroenterology"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","article-title":"SOX2 in development and cancer biology","volume":"67","author":"Novak","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2559.2005.02170.x","article-title":"SOX2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes","volume":"46","author":"Tsukamoto","year":"2005","journal-title":"Histopathology"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"e2491","DOI":"10.1097\/MD.0000000000002491","article-title":"Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma","volume":"95","author":"Andrici","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ajcp\/aqz032","article-title":"Albumin in situ hybridization can be positive in adenocarcinomas and other tumors from diverse sites","volume":"152","author":"Nasir","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/his.13894","article-title":"Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas","volume":"75","author":"Ritterhouse","year":"2019","journal-title":"Histopathology"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.4200","article-title":"Gene expression profiling of serrated polyps identifies Annexin a10 as a marker of a sessile serrated adenoma\/polyp","volume":"230","author":"Gonzalo","year":"2013","journal-title":"J Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"9749","DOI":"10.3748\/wjg.v21.i33.9749","article-title":"Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway","volume":"21","author":"Bae","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/PAS.0000000000000148","article-title":"Immunohistochemistry for Annexin A10 can distinguish sporadic from lynch syndrome-associated microsatellite-unstable colorectal carcinoma","volume":"38","author":"Pai","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-014-1683-6","article-title":"Annexin A10 is a marker for the serrated pathway of colorectal carcinoma","volume":"466","author":"Sajanti","year":"2015","journal-title":"Virchows Arch"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/modpathol.2014.96","article-title":"Aberrant expression of Annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma","volume":"28","author":"Tsai","year":"2015","journal-title":"Mod Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/his.12229","article-title":"Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system","volume":"63","author":"Lu","year":"2013","journal-title":"Histopathology"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PAS.0000000000001583","article-title":"Claudin-18 as a marker for identifying the stomach and pancreatobiliary tract as the primary sites of metastatic adenocarcinoma","volume":"44","author":"Li","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat Med"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-017-0473-4","article-title":"Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer","volume":"10","author":"Singh","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.humpath.2009.06.006","article-title":"SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract","volume":"40","author":"Long","year":"2009","journal-title":"Hum Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1309\/AJCP7MNCNBCRN8NO","article-title":"Differential expression of SOX2 and SOX17 in testicular germ cell tumors","volume":"131","author":"Nonaka","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semcancer.2020.05.007","article-title":"SOX2 and squamous cancers","volume":"67","author":"Porter","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.2147\/CMAR.S219568","article-title":"Increased expression of SOX2 predicts a poor prognosis and promotes malignant phenotypes in upper tract urothelial carcinoma","volume":"11","author":"Bao","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"e101957","DOI":"10.1371\/journal.pone.0101957","article-title":"SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer","volume":"9","author":"Lundberg","year":"2014","journal-title":"PLoS ONE"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2019.03.099","article-title":"SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma","volume":"153","author":"Sherman-Samis","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/PAS.0b013e3181e5e024","article-title":"SOX2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma","volume":"34","author":"Sholl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2015.260","article-title":"SOX2 as a novel marker to predict neoplastic progression in Barrett\u2019s esophagus","volume":"110","author":"van Olphen","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1593\/neo.04715","article-title":"Altered expression of TFF-1 and CES-2 in Barrett\u2019s esophagus and associated adenocarcinomas","volume":"7","author":"Fox","year":"2005","journal-title":"Neoplasia"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/bjc.1991.380","article-title":"Expression of the PNR-2\/PS2 protein in diverse human epithelial tumours","volume":"64","author":"Henry","year":"1991","journal-title":"Br J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:01:13Z","timestamp":1749416473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001994","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}